Table 1.

Summary of Publications Describing Residual and Persistent Symptoms of COVID-19

Author,a Publication Date Country	No. of Patients Included	Median Age of Patients Included, y	Males, %	Study Mean Follow-up Time, d	Patient Locationb and Reported Symptoms, %
Carfi, July 9c Italy [6]	143	56.5	63	60.3d	Outpatiente
					Fatigue	53.1
					Dyspnea	43.4
					Arthralgias	27.3
Halpin, July 30c   UK [7]	100 (Ward 68; ICU 32)	Ward 70.5 ICU 58.5	Ward 51.5 ICU 59.4	48f	Ward
					New fatigueg	60.3
					Breathlessnessg	42.6
					PTSDg	23.5
					Concentration & memory deficits	33.8
					Speech & swallow deficitsh	42.6
					ICU
					New fatigueg	72
					Breathlessnessg	65.6
					PTSDg	46.9
					Concentration & memory deficits	53.1
					Speech & swallow deficitsh	68.7
Tenforde, July 24c   USA [9]	274	42.5	48	14–21i	ED or outpatient clinics
					Cough	43
					Fatigue	35
					Dyspnea	29
Garrigues, August 21c   France [8]	120 (Ward 96; ICU 24)	Ward 64.1 ICU 59.6	Ward 58.3 ICU 79.2	110.9j	Ward

Abbreviations: COVID-19, coronavirus disease 2019; ICU, intensive care unit; ward, general medical ward.

^aFirst author.

^bPatient location at the time study data were collected.

^cPublication year 2020.

^dFollow-up in days since initial symptoms.

^ePatients previously hospitalized for COVID-19.

^fFollow-up in days since hospital discharge.

^gSymptom reported for any severity.

^hSymptoms include difficulty swallowing, communicating, laryngeal sensitivity, and voice change.

ⁱDays from test date.

^jFollow-up in days since hospital admission.